Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Return on Sales (2021 - 2025)

Historic Return on Sales for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to 0.0%.

  • Immunocore Holdings' Return on Sales fell 1100.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.16% for FY2024, which is 600.0% up from last year.
  • Latest data reveals that Immunocore Holdings reported Return on Sales of 0.0% as of Q3 2025, which was down 1100.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Return on Sales registered a high of 0.11% during Q3 2024, and its lowest value of 5.91% during Q4 2021.
  • Moreover, its 5-year median value for Return on Sales was 0.27% (2022), whereas its average is 1.1%.
  • In the last 5 years, Immunocore Holdings' Return on Sales surged by 56500bps in 2022 and then tumbled by -1100bps in 2025.
  • Immunocore Holdings' Return on Sales (Quarter) stood at 5.91% in 2021, then skyrocketed by 96bps to 0.26% in 2022, then dropped by -9bps to 0.28% in 2023, then dropped by -1bps to 0.28% in 2024, then soared by 99bps to 0.0% in 2025.
  • Its Return on Sales was 0.0% in Q3 2025, compared to 0.11% in Q2 2025 and 0.05% in Q1 2025.